Selected article for: "epithelial cell and pulmonary epithelial cell"
Author: Arjmand, Sareh; Hosseinkhan, Nazanin
Title: Identification of potential coagulation pathway abnormalities in SARS-Cov-2 infection; insights from bioinformatics analysis
  • Cord-id: 1gr2a9c7
  • Document date: 2020_12_7
    • ID: 1gr2a9c7
    Snippet: Abnormal coagulation parameters have been explored in a significant number of severe COVID-19 patients, linked to poor prognosis and increased risk of organ failure. Here, to uncover the potential abnormalities in coagulation pathways, we analyzed the RNA-seq data (GEO147507) obtained from the treatment of three pulmonary epithelial cell lines with SARS-CoV-2. The significant differentially expressed genes (DEGs) were subjected to Enrichr database for KEGG pathway enrichment analysis and gene on
    Document: Abnormal coagulation parameters have been explored in a significant number of severe COVID-19 patients, linked to poor prognosis and increased risk of organ failure. Here, to uncover the potential abnormalities in coagulation pathways, we analyzed the RNA-seq data (GEO147507) obtained from the treatment of three pulmonary epithelial cell lines with SARS-CoV-2. The significant differentially expressed genes (DEGs) were subjected to Enrichr database for KEGG pathway enrichment analysis and gene ontology (GO) functional annotation. The STRING database was used to generate PPI networks for identified DEGs. We found three upregulated procoagulant genes (SERPINE1, SERPINA5, and SERPINB2) belong to the serine protease inhibitor (serpin) superfamily that inhibit tissue plasminogen activator (t-PA) and urokinase plasminogen activator (u-PA) in the fibrinolysis process. In conclusion, we suggest the fibrinolysis process, especially the blockage of t-PA and u-PA inhibitors, a potential target for more study in treating coagulopathy in severe COVID-19 cases.

    Search related documents:
    Co phrase search for related documents
    • activate protein and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • activate protein and acute respiratory distress syndrome: 1
    • activate protein and liver damage: 1
    • activate protein and liver kidney: 1
    • activate protein and lung alveolar: 1
    • activate protein and lung inflammation: 1, 2
    • activate protein and lung injury: 1
    • active form and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
    • active form and acute respiratory distress syndrome: 1
    • active form and liver damage: 1
    • active form and liver kidney: 1
    • active form and lung epithelium: 1
    • active form and lung inflammation: 1
    • active form convert and acute respiratory: 1
    • active protein and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
    • active protein and acute respiratory distress syndrome: 1
    • active protein and lung alveolar: 1, 2
    • active protein and lung injury: 1